890 followers
Olaparib. https://t.co/03ek6AfKtL
Small Molecules in Oncology
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Erlotinib
-
Altmetric BadgeChapter 2 Lapatinib
-
Altmetric BadgeChapter 3 Regorafenib
-
Altmetric BadgeChapter 4 Crizotinib
-
Altmetric BadgeChapter 5 Cabozantinib: Multi-kinase Inhibitor of MET, AXL, RET, and VEGFR2
-
Altmetric BadgeChapter 6 Vemurafenib
-
Altmetric BadgeChapter 7 Trametinib (GSK1120212)
-
Altmetric BadgeChapter 8 Everolimus
-
Altmetric BadgeChapter 9 Vismodegib
-
Altmetric BadgeChapter 10 Larotrectinib (LOXO-101)
-
Altmetric BadgeChapter 11 Palbociclib—The First of a New Class of Cell Cycle Inhibitors
-
Altmetric BadgeChapter 12 Cobimetinib (GDC-0973, XL518)
-
Altmetric BadgeChapter 13 Lenvantinib: A Tyrosine Kinase Inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, KIT and RET
-
Altmetric BadgeChapter 14 Afatinib
-
Altmetric BadgeChapter 15 Olaparib
-
Altmetric BadgeChapter 16 Gefitinib
-
Altmetric BadgeChapter 17 Alectinib
-
Altmetric BadgeChapter 18 Osimertinib
Altmetric Badge
About this Attention Score
-
Among the highest-scoring outputs from this source (#48 of 172)
-
Good Attention Score compared to outputs of the same age (67th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)
Citations
- dimensions_citation
- 14 Dimensions
Readers on
- mendeley
- 166 Mendeley